Director – Brand Insights & Competitive Intelligence
ITF Therapeutics
Director – Brand Insights & Competitive Intelligence
ITF Therapeutics
Develops and commercializes rare-disease therapies
The Director, Brand Insights & Competitive Intelligence, will lead the integration of insights from Market Research, Competitive Intelligence, and other relevant data sources, partnering with Marketing, Medical Affairs, Market Access, and Commercial Leadership to translate evolving market, scientific, customer, and patient dynamics into actionable strategic recommendations for a Phase III neurometabolic asset.
What You’ll Do
Insights Strategy & Roadmap:
Market Insights:
Integrated Insights + Strategic Decision Support:
Competitive Intelligence (CI):
Who You Are & Required Skills
Additional Information:
The base compensation range for this role is $230,000 - $250,000. Compensation is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Develops and commercializes rare-disease therapies
ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.
Explore more opportunities at ITF Therapeutics